BiotechTube
Home/Homology Medicines/Albert Seymour, Ph.D.
AS

Albert Seymour, Ph.D.

President and Chief Executive Officer

Homology Medicines

Therapeutic Areas

Rare Genetic DiseasesMetabolic DisordersLysosomal Storage Disorders

Homology Medicines Pipeline

DrugIndicationPhase
HMI-102Phenylketonuria (PKU) in adultsPhase 1/2
HMI-103Phenylketonuria (PKU) in pediatric patientsPreclinical
HMI-203Hunter Syndrome (MPS II)Preclinical
HMI-204Metachromatic Leukodystrophy (MLD)Preclinical

Leadership Team at Homology Medicines

WB
W. Bradford Smith
Chief Financial Officer
SC
Saswati Chatterjee, Ph.D.
Scientific Founder
View full Homology Medicines profile